Cargando…
From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the nicotinamide adenine dinucleotide (NAD) salvage pathway in mammals. It is of great significance in the metabolic homeostasis and cell survival via synthesizing nicotinamide mononucleotide (NMN) through enzymatic activi...
Autores principales: | Zhu, Yumeng, Xu, Ping, Huang, Xuan, Shuai, Wen, Liu, Li, Zhang, Shuai, Zhao, Rui, Hu, Xiuying, Wang, Guan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322656/ https://www.ncbi.nlm.nih.gov/pubmed/35903330 http://dx.doi.org/10.3389/fphar.2022.920113 |
Ejemplares similares
-
Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010) -
MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
por: Han, Dong, et al.
Publicado: (2020) -
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020) -
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021) -
Review of various NAMPT inhibitors for the treatment of cancer
por: Wei, Yichen, et al.
Publicado: (2022)